The hookworm pharmacopoeia for inflammatory diseases

International Journal for Parasitology

Volumn 43, Issue 3-4, 2013, Pages 225-231

  Navarro, Severine ^a   Ferreira, Ivana ^a   Loukas, Alex ^a  

^a JAMES COOK UNIVERSITY   (Australia)

Author keywords

Asthma; Excretory secretory; Hookworm; Hygiene hypothesis; Inflammatory bowel disease; Therapeutic

Indexed keywords

CALRETICULIN; EXCRETORY SECRETORY PROTEIN; GLYCOPROTEIN; HELMINTH PROTEIN; LOW MOLECULAR WEIGHT HEPARIN; NEMATODE ANTICOAGULANT PEPTIDE C2; NEUTROPHIL INHIBITORY FACTOR; PARASITE ANTIGEN; SECRETORY PROTEIN; TISSUE PLASMINOGEN ACTIVATOR; UK 279276; UNCLASSIFIED DRUG;

ALLERGY; ASTHMA; HYGIENE; IDENTIFICATION METHOD; IMMUNE SYSTEM; INFECTIVITY; PARASITE; PARASITIC DISEASE; PATHOLOGY; PROTEIN;

ALLERGIC ASTHMA; ANCYLOSTOMA CEYLANICUM; ANTICOAGULATION; ARTICLE; BRAIN ISCHEMIA; CELIAC DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL (TOPIC); COLITIS; CROHN DISEASE; DEEP VEIN THROMBOSIS; DOSE RESPONSE; DRUG HALF LIFE; DRUG MEGADOSE; ENTERITIS; GLUTEN FREE DIET; HOOKWORM; HOOKWORM INFECTION; HOST PARASITE INTERACTION; HUMAN; IMMUNOMODULATION; INFLAMMATORY DISEASE; LOW DRUG DOSE; NECATOR AMERICANUS; NECATORIASIS; NEUROPROTECTION; NONHUMAN; PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); THERAPY WITH HELMINTHS; TRICHURIS SUIS; ULCERATIVE COLITIS;

ANCYLOSTOMATOIDEA; ANIMALS; HELMINTH PROTEINS; HUMANS; IMMUNE SYSTEM DISEASES; THERAPY WITH HELMINTHS;

ANCYLOSTOMATOIDEA;

EID: 84873732487     PISSN: 00207519     EISSN: 18790135     Source Type: Journal    
DOI: 10.1016/j.ijpara.2012.11.005     Document Type: Article

References (92)

1. Akdis M., Verhagen J., Taylor A., Karamloo F., Karagiannidis C., Crameri R., Thunberg S., Deniz G., Valenta R., Fiebig H., Kegel C., Disch R., Schmidt-Weber C.B., Blaser K., Akdis C.A. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J. Exp. Med. 2004, 199:1567-1575.
2. Australian Centre for Asthma Monitoring Asthma in Australia 2011 2011, Canberra, Australia.
3. Barnes P.J. Immunology of asthma and chronic obstructive pulmonary disease. Nat. Rev. Immunol. 2008, 8:183-192.
4. Bethony J., Loukas A., Smout M., Brooker S., Mendez S., Plieskatt J., Goud G., Bottazzi M.E., Zhan B., Wang Y., Williamson A., Lustigman S., Correa-Oliveira R., Xiao S., Hotez P.J. Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals. FASEB J. 2005, 19:1743-1745.
5. Bethony J., Brooker S., Albonico M., Geiger S.M., Loukas A., Diemert D., Hotez P.J. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 2006, 367:1521-1532.
6. Blount D., Hooi D., Feary J., Venn A., Telford G., Brown A., Britton J., Pritchard D. Immunologic profiles of persons recruited for a randomized, placebo-controlled clinical trial of hookworm infection. Am. J. Trop. Med. Hyg. 2009, 81:911-916.
7. Borkow G., Leng Q., Weisman Z., Stein M., Galai N., Kalinkovich A., Bentwich Z. Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy. J. Clin. Invest. 2000, 106:1053-1060.
8. Broadhurst M.J., Leung J.M., Kashyap V., McCune J.M., Mahadevan U., McKerrow J.H., Loke P. IL-22+CD4+ T cells are associated with therapeutic Trichuris trichiura infection in an ulcerative colitis patient. Sci. Tranls. Med. 2010, 2:60ra88.
9. Buddai S.K., Toulokhonova L., Bergum P.W., Vlasuk G.P., Krishnaswamy S. Nematode anticoagulant protein c2 reveals a site on factor Xa that is important for macromolecular substrate binding to human prothrombinase. J. Biol. Chem. 2002, 277:26689-26698.
10. Cancado G.G., Fiuza J.A., de Paiva N.C., Lemos Lde C., Ricci N.D., Gazzinelli-Guimaraes P.H., Martins V.G., Bartholomeu D.C., Negrao-Correa D.A., Carneiro C.M., Fujiwara R.T. Hookworm products ameliorate dextran sodium sulfate-induced colitis in BALB/c mice. Inflamm. Bowel Dis. 2011, 17:2275-2286.
11. Cantacessi C., Mitreva M., Jex A.R., Young N.D., Campbell B.E., Hall R.S., Doyle M.A., Ralph S.A., Rabelo E.M., Ranganathan S., Sternberg P.W., Loukas A., Gasser R.B. Massively parallel sequencing and analysis of the Necator americanus transcriptome. PLoS Neglect. Trop. Dis. 2010, 4:e684.
12. Cappello M., Vlasuk G.P., Bergum P.W., Huang S., Hotez P.J. Ancylostoma caninum anticoagulant peptide: a hookworm-derived inhibitor of human coagulation factor Xa. Proc. Natl. Acad. Sci. USA 1995, 92:6152-6156.
13. Cohn L., Elias J.A., Chupp G.L. Asthma: mechanisms of disease persistence and progression. Ann. Rev. Immunol. 2004, 22:789-815.
14. Cooper P.J., Chico M.E., Rodrigues L.C., Ordonez M., Strachan D., Griffin G.E., Nutman T.B. Reduced risk of atopy among school-age children infected with geohelminth parasites in a rural area of the tropics. J. Allerg. Clin. Immunol. 2003, 111:995-1000.
15. Croese J., O'Neil J., Masson J., Cooke S., Melrose W., Pritchard D., Speare R. A proof of concept study establishing Necator americanus in Crohn's patients and reservoir donors. Gut 2006, 55:136-137.
16. Cuellar C., Wu W., Mendez S. The hookworm tissue inhibitor of metalloproteases (Ac-TMP-1) modifies dendritic cell function and induces generation of CD4 and CD8 suppressor T cells. PLoS Neglect. Trop. Dis. 2009, 3:e439.
17. Dagoye D., Bekele Z., Woldemichael K., Nida H., Yimam M., Hall A., Venn A.J., Britton J.R., Hubbard R., Lewis S.A. Wheezing, allergy, and parasite infection in children in urban and rural Ethiopia. Am. J. Resp. Crit. Care Med. 2003, 167:1369-1373.
18. Datu B.J., Gasser R.B., Nagaraj S.H., Ong E.K., O'Donoghue P., McInnes R., Ranganathan S., Loukas A. Transcriptional changes in the hookworm, Ancylostoma caninum, during the transition from a free-living to a parasitic larva. PLoS Neglect. Trop. Dis. 2008, 2:e130.
19. Daveson A.J., Jones D.M., Gaze S., McSorley H., Clouston A., Pascoe A., Cooke S., Speare R., Macdonald G.A., Anderson R., McCarthy J.S., Loukas A., Croese J. Effect of hookworm infection on wheat challenge in celiac disease - a randomised double-blinded placebo controlled trial. PLoS ONE 2011, 6:e17366.
20. Donnelly S., O'Neill S.M., Stack C.M., Robinson M.W., Turnbull L., Whitchurch C., Dalton J.P. Helminth cysteine proteases inhibit TRIF-dependent activation of macrophages via degradation of TLR3. J. Biol. Chem. 2010, 285:3383-3392.
21. Feary J., Venn A., Brown A., Hooi D., Falcone F.H., Mortimer K., Pritchard D.I., Britton J. Safety of hookworm infection in individuals with measurable airway responsiveness: a randomized placebo-controlled feasibility study. Clin. Exp. Allerg. 2009, 39:1060-1068.
22. Feary J.R., Venn A.J., Mortimer K., Brown A.P., Hooi D., Falcone F.H., Pritchard D.I., Britton J.R. Experimental hookworm infection: a randomized placebo-controlled trial in asthma. Clin. Exp. Allerg. 2010, 40:299-306.
23. Feng B.S., Zheng P.Y., Chen X., Liao X.Q., Yang P.C. Investigation of the role of cholera toxin in assisting the initiation of the antigen-specific Th2 response. Immunol. Invest. 2008, 37:782-797.
24. Finkelman F.D., Hogan S.P., Hershey G.K., Rothenberg M.E., Wills-Karp M. Importance of cytokines in murine allergic airway disease and human asthma. J. Immunol. 2010, 184:1663-1674.
25. Fleming J.O. Helminths and multiple sclerosis: will old friends give us new treatments for MS?. J. Neuroimmunol. 2011, 233:3-5.
26. Flohr C., Quinnell R.J., Britton J. Do helminth parasites protect against atopy and allergic disease?. Clin. Exp. Allerg. 2009, 39:20-32.
27. Furman B.L. The development of Byetta (exenatide) from the venom of the Gila monster as an anti-diabetic agent. Toxicon 2012, 59:464-471.
28. Gaze S., McSorley H.J., Daveson J., Jones D., Bethony J.M., Oliveira L.M., Speare R., McCarthy J.S., Engwerda C.R., Croese J., Loukas A. Characterising the mucosal and systemic immune responses to experimental human hookworm infection. PLoS Pathol. 2012, 8:e1002520.
29. Geiger S.M., Caldas I.R., Mc Glone B.E., Campi-Azevedo A.C., De Oliveira L.M., Brooker S., Diemert D., Correa-Oliveira R., Bethony J.M. Stage-specific immune responses in human Necator americanus infection. Parasite Immunol. 2007, 29:347-358.
30. Geiger S.M., Fujiwara R.T., Santiago H., Correa-Oliveira R., Bethony J.M. Early stage-specific immune responses in primary experimental human hookworm infection. Microbes Infect. 2008, 10:1524-1535.
31. Geremia A., Jewell D.P. The IL-23/IL-17 pathway in inflammatory bowel disease. Exp. Rev. Gastroenterol. Hepatol. 2012, 6:223-237.
32. Holgate S.T. Innate and adaptive immune responses in asthma. Nat. Med. 2012, 18:673-683.
33. Hotez P.J., Brooker S., Bethony J.M., Bottazzi M.E., Loukas A., Xiao S. Hookworm infection. New Engl. J. Med. 2004, 351:799-807.
34. Hotez P.J., Bethony J., Bottazzi M.E., Brooker S., Buss P. Hookworm: "the great infection of mankind" PLoS Med. 2005, 2:e67.
35. Hsieh G.C., Loukas A., Wahl A.M., Bhatia M., Wang Y., Williamson A.L., Kehn K.W., Maruyama H., Hotez P.J., Leitenberg D., Bethony J., Constant S.L. A secreted protein from the human hookworm Necator americanus binds selectively to NK cells and induces IFN-gamma production. J. Immunol. 2004, 173:2699-2704.
36. Huang S.L., Tsai P.F., Yeh Y.F. Negative association of Enterobius infestation with asthma and rhinitis in primary school children in Taipei. Clin. Exp. Allerg. 2002, 32:1029-1032.
37. Jiang N., Chopp M., Chahwala S. Neutrophil inhibitory factor treatment of focal cerebral ischemia in the rat. Brain Res. 1998, 788:25-34.
38. Jonkers D., Penders J., Masclee A., Pierik M. Probiotics in the management of inflammatory bowel disease: a systematic review of intervention studies in adult patients. Drugs 2012, 72:803-823.
39. Kanai T., Mikami Y., Sujino T., Hisamatsu T., Hibi T. RORgammat-dependent IL-17A-producing cells in the pathogenesis of intestinal inflammation. Mucosal Immunol. 2012, 5:240-247.
40. Kasper G., Brown A., Eberl M., Vallar L., Kieffer N., Berry C., Girdwood K., Eggleton P., Quinnell R., Pritchard D.I. A calreticulin-like molecule from the human hookworm Necator americanus interacts with C1q and the cytoplasmic signalling domains of some integrins. Parasite Immunol. 2001, 23:141-152.
41. Krams M., Lees K.R., Hacke W., Grieve A.P., Orgogozo J.M., Ford G.A. Acute stroke therapy by inhibition of neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke 2003, 34:2543-2548.
42. Lee A., Agnelli G., Buller H., Ginsberg J., Heit J., Rote W., Vlasuk G., Costantini L., Julian J., Comp P., van Der Meer J., Piovella F., Raskob G., Gent M. Dose-response study of recombinant factor VIIa/tissue factor inhibitor recombinant nematode anticoagulant protein c2 in prevention of postoperative venous thromboembolism in patients undergoing total knee replacement. Circulation 2001, 104:74-78.
43. Leonardi-Bee J., Pritchard D., Britton J. Asthma and current intestinal parasite infection: systematic review and meta-analysis. Am. J. Resp. Crit. Care Med. 2006, 174:514-523.
44. Li R.W., Wu S., Li W., Navarro K., Couch R.D., Hill D., Urban J.F. Alterations in the porcine colon microbiota induced by the gastrointestinal nematode Trichuris suis. Infect. Immun. 2012, 80:2150-2157.
45. Ling E.M., Smith T., Nguyen X.D., Pridgeon C., Dallman M., Arbery J., Carr V.A., Robinson D.S. Relation of CD4+CD25+ regulatory T-cell suppression of allergen-driven T-cell activation to atopic status and expression of allergic disease. Lancet 2004, 363:608-615.
46. Lynch N.R., Lopez R.I., Di Prisco-Fuenmayor M.C., Hagel I., Medouze L., Viana G., Ortega C., Prato G. Allergic reactivity and socio-economic level in a tropical environment. Clin. Allerg. 1987, 17:199-207.
47. Lynch N.R., Hagel I., Perez M., Di Prisco M.C., Lopez R., Alvarez N. Effect of anthelmintic treatment on the allergic reactivity of children in a tropical slum. J. Allerg. Clin. Immunol. 1993, 92:404-411.
48. MacGlashan D.W., Bochner B.S., Adelman D.C., Jardieu P.M., Togias A., Lichtenstein L.M. Serum IgE level drives basophil and mast cell IgE receptor display. Int. Arch. Allergy Immunol. 1997, 113:45-47.
49. Maloy K.J., Powrie F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 2011, 474:298-306.
50. McSorley H.J., Loukas A. The immunology of human hookworm infections. Parasite Immunol. 2010, 32:549-559.
51. McSorley H.J., Gaze S., Daveson J., Jones D., Anderson R.P., Clouston A., Ruyssers N.E., Speare R., McCarthy J.S., Engwerda C.R., Croese J., Loukas A. Suppression of inflammatory immune responses in celiac disease by experimental hookworm infection. PLoS ONE 2011, 6:e24092.
52. Molodecky N.A., Soon I.S., Rabi D.M., Ghali W.A., Ferris M., Chernoff G., Benchimol E.I., Panaccione R., Ghosh S., Barkema H.W., Kaplan G.G. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012, 142:46-54. e42; quiz e30.
53. Mortimer K., Brown A., Feary J., Jagger C., Lewis S., Antoniak M., Pritchard D., Britton J. Dose-ranging study for trials of therapeutic infection with Necator americanus in humans. Am. J. Trop. Med. Hyg. 2006, 75:914-920.
54. Moyle M., Foster D.L., McGrath D.E., Brown S.M., Laroche Y., De Meutter J., Stanssens P., Bogowitz C.A., Fried V.A., Ely J.A., et al. A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18. J. Biol. Chem. 1994, 269:10008-10015.
55. Muchowski P.J., Zhang L., Chang E.R., Soule H.R., Plow E.F., Moyle M. Functional interaction between the integrin antagonist neutrophil inhibitory factor and the I domain of CD11b/CD18. J. Biol. Chem. 1994, 269:26419-26423.
56. Mulvenna J., Hamilton B., Nagaraj S.H., Smyth D., Loukas A., Gorman J.J. Proteomics analysis of the excretory/secretory component of the blood-feeding stage of the hookworm, Ancylostoma caninum. Mol. Cell. Proteomics 2009, 8:109-121.
57. Nguyen T.T., Qasim M.A., Morris S., Lu C.C., Hill D., Laskowski M., Sakanari J.A. Expression and characterization of elastase inhibitors from the ascarid nematodes Anisakis simplex and Ascaris suum. Mol. Biochem. Parasitol. 1999, 102:79-89.
58. Nowak G., Schror K. Hirudin - the long and stony way from an anticoagulant peptide in the saliva of medicinal leech to a recombinant drug and beyond. A historical piece. Thromb. Haem. 2007, 98:116-119.
59. Nyan O.A., Walraven G.E., Banya W.A., Milligan P., Van Der Sande M., Ceesay S.M., Del Prete G., McAdam K.P. Atopy, intestinal helminth infection and total serum IgE in rural and urban adult Gambian communities. Clin. Exp. Allerg. 2001, 31:1672-1678.
60. Pages F., Lazar V., Berger A., Danel C., Lebel-Binay S., Zinzindohoue F., Desreumaux P., Cellier C., Thiounn N., Bellet D., Cugnenc P.H., Fridman W.H. Analysis of interleukin-18, interleukin-1 converting enzyme (ICE) and interleukin-18-related cytokines in Crohn's disease lesions. Eur. Cytokine Netw. 2001, 12:97-104.
61. Palmer E.D. Course of egg output over a 15year period in a case of experimentally induced necatoriasis americanus, in the absence of hyperinfection. Am. J. Trop. Med. Hyg. 1955, 4:756-757.
62. Patel S.P., Jarvelin M.R., Little M.P. Systematic review of worldwide variations of the prevalence of wheezing symptoms in children. Environ. Health 2008, 7:57.
63. Pearson M.S., Ranjit N., Loukas A. Blunting the knife: development of vaccines targeting digestive proteases of blood-feeding helminth parasites. Biol. Chem. 2010, 391:901-911.
64. Pit D.S., Polderman A.M., Baeta S., Schulz-Key H., Soboslay P.T. Parasite-specific antibody and cellular immune responses in human infected with Necator americanus and Oesophagostomum bifurcum. Parasitol. Res. 2001, 87:722-729.
65. Prescott S., Allen K.J. Food allergy: riding the second wave of the allergy epidemic. Pediatr. Allerg. Immunol. 2011, 22:155-160.
66. Pritchard D.I., Brown A. Is Necator americanus approaching a mutualistic symbiotic relationship with humans?. Trends Parasitol. 2001, 17:169-172.
67. Pritchard D.I., Blount D.G., Schmid-Grendelmeier P., Till S.J. Parasitic worm therapy for allergy: is this incongruous or avant-garde medicine?. Clin. Exp. Allerg. 2012, 42:505-512.
68. Quinnell R.J., Bethony J., Pritchard D.I. The immunoepidemiology of human hookworm infection. Parasite Immunol. 2004, 26:443-454.
69. Quinnell R.J., Pritchard D.I., Raiko A., Brown A.P., Shaw M.A. Immune responses in human necatoriasis: association between interleukin-5 responses and resistance to reinfection. J. Infect. Dis. 2004, 190:430-438.
70. Ricci N.D., Fiuza J.A., Bueno L.L., Cancado G.G., Gazzinelli-Guimaraes P.H., Martins V.G., Matoso L.F., de Miranda R.R., Geiger S.M., Correa-Oliveira R., Gazzinelli A., Bartholomeu D.C., Fujiwara R.T. Induction of CD4(+)CD25(+)FOXP3(+) regulatory T cells during human hookworm infection modulates antigen-mediated lymphocyte proliferation. PLoS Neglect. Trop. Dis. 2011, 5:e1383.
71. Rook G.A., Brunet L.R. Old friends for breakfast. Clin. Exp. Allerg. 2005, 35:841-842.
72. Rook G.A. Hygiene hypothesis and autoimmune diseases. Clin. Rev. Allerg. Immunol. 2012, 42:5-15.
73. Ruyssers N.E., De Winter B.Y., De Man J.G., Loukas A., Pearson M.S., Weinstock J.V., Van den Bossche R.M., Martinet W., Pelckmans P.A., Moreels T.G. Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm. Bowel Dis. 2009, 15:491-500.
74. Saenz S.A., Siracusa M.C., Perrigoue J.G., Spencer S.P., Urban J.F., Tocker J.E., Budelsky A.L., Kleinschek M.A., Kastelein R.A., Kambayashi T., Bhandoola A., Artis D. IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses. Nature 2010, 464:1362-1366.
75. Schnoeller C., Rausch S., Pillai S., Avagyan A., Wittig B.M., Loddenkemper C., Hamann A., Hamelmann E., Lucius R., Hartmann S. A helminth immunomodulator reduces allergic and inflammatory responses by induction of IL-10-producing macrophages. J. Immunol. 2008, 180:4265-4272.
76. Schuppan D., Junker Y., Barisani D. Celiac disease: from pathogenesis to novel therapies. Gastroenterology 2009, 137:1912-1933.
77. Scrivener S., Yemaneberhan H., Zebenigus M., Tilahun D., Girma S., Ali S., McElroy P., Custovic A., Woodcock A., Pritchard D., Venn A., Britton J. Independent effects of intestinal parasite infection and domestic allergen exposure on risk of wheeze in Ethiopia: a nested case-control study. Lancet 2001, 358:1493-1499.
78. Selassie F.G., Stevens R.H., Cullinan P., Pritchard D., Jones M., Harris J., Ayres J.G., Newman Taylor A.J. Total and specific IgE (house dust mite and intestinal helminths) in asthmatics and controls from Gondar, Ethiopia. Clin. Exp. Allerg. 2000, 30:356-358.
79. Smits H.H., Everts B., Hartgers F.C., Yazdanbakhsh M. Chronic helminth infections protect against allergic diseases by active regulatory processes. Curr. Allerg. Asthma Rep. 2010, 10:3-12.
80. Stassens P., Bergum P.W., Gansemans Y., Jespers L., Laroche Y., Huang S., Maki S., Messens J., Lauwereys M., Cappello M., Hotez P.J., Lasters I., Vlasuk G.P. Anticoagulant repertoire of the hookworm Ancylostoma caninum. Proc. Natl. Acad. Sci. USA 1996, 93:2149-2154.
81. Strachan D.P. Hay fever, hygiene, and household size. Br. Med. J. 1989, 299:1259-1260.
82. Summers R.W., Elliott D.E., Qadir K., Urban J.F., Thompson R., Weinstock J.V. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am. J. Gastroenterol. 2003, 98:2034-2041.
83. Summers R.W., Elliott D.E., Urban J.F., Thompson R.A., Weinstock J.V. Trichuris suis therapy for active ulcerative colitis: a randomized controlled trial. Gastroenterology 2005, 128:825-832.
84. van den Biggelaar A.H., Rodrigues L.C., van Ree R., van der Zee J.S., Hoeksma-Kruize Y.C., Souverijn J.H., Missinou M.A., Borrmann S., Kremsner P.G., Yazdanbakhsh M. Long-term treatment of intestinal helminths increases mite skin-test reactivity in Gabonese schoolchildren. J. Infect. Dis. 2004, 189:892-900.
85. Vlasuk G.P., Bradbury A., Lopez-Kinninger L., Colon S., Bergum P.W., Maki S., Rote W.E. Pharmacokinetics and anticoagulant properties of the factor VIIa-tissue factor inhibitor recombinant Nematode Anticoagulant Protein c2 following subcutaneous administration in man. Dependence on the stoichiometric binding to circulating factor X. Thromb. Haem. 2003, 90:803-812.
86. Wang Z., Abubucker S., Martin J., Wilson R.K., Hawdon J., Mitreva M. Characterizing Ancylostoma caninum transcriptome and exploring nematode parasitic adaptation. BMC Genomics 2010, 11:307.
87. Weinstock J.V., Elliott D.E. Helminths and the IBD hygiene hypothesis. Inflamm. Bowel Dis. 2009, 15:128-133.
88. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Ann. Rev. Immunol. 1999, 17:255-281.
89. Wright V., Bickle Q. Immune responses following experimental human hookworm infection. Clin. Exp. Immunol. 2005, 142:398-403.
90. Yazdanbakhsh M., Kremsner P.G., van Ree R. Allergy, parasites, and the hygiene hypothesis. Science 2002, 296:490-494.
91. Yazdanbakhsh M., van den Biggelaar A., Maizels R.M. Th2 responses without atopy: immunoregulation in chronic helminth infections and reduced allergic disease. Trends Immunol. 2001, 22:372-377.
92. Zhang L., Zhang Z.G., Zhang R.L., Lu M., Krams M., Chopp M. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke. Stroke 2003, 34:1790-1795.